# United States Antimony Corp: financial statements, quarterly

UAMY · NYSE · CIK 101538 · [Materials](/sectors/materials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/uamy.md) · [Financials](/companies/uamy/financials.md) · [Filings](/companies/uamy/filings.md) · [Insiders](/companies/uamy/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/uamy/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [2.1](/filings/0001654954-24-014176.md) | [2.2 d](/filings/0001654954-25-004433.md) | [3.1](/filings/0001654954-25-005221.md) | [3.7](/filings/0001654954-25-009449.md) | [2.6](/filings/0001104659-25-110313.md) | [5.6 d](/filings/0001104659-26-032049.md) | [7.0](/filings/0001104659-26-061193.md) | [10.5](/filings/0001104659-26-094035.md) | [8.7](/filings/0001104659-25-110313.md) | [13.0 d](/filings/0001104659-26-032049.md) | [6.8](/filings/0001104659-26-061193.md) | [7.9](/filings/0001104659-26-094035.md) |
| Cost of revenue | $m | [1.8](/filings/0001654954-24-014176.md) | [6.5 d](/filings/0001654954-25-004433.md) | [2.5](/filings/0001654954-25-005221.md) | [2.4](/filings/0001654954-25-009449.md) | [2.1](/filings/0001104659-25-110313.md) | [4.4 d](/filings/0001104659-26-032049.md) | [4.6](/filings/0001104659-26-061193.md) | [7.7](/filings/0001104659-26-094035.md) | [6.7](/filings/0001104659-25-110313.md) | [10.4 d](/filings/0001104659-26-032049.md) | [5.7](/filings/0001104659-26-061193.md) | [7.3](/filings/0001104659-26-094035.md) |
| Gross profit | $m | [0.3](/filings/0001654954-24-014176.md) | [(4.4) d](/filings/0001654954-25-004433.md) | [0.6](/filings/0001654954-25-005221.md) | [1.3](/filings/0001654954-25-009449.md) | [0.4](/filings/0001104659-25-110313.md) | [1.2 d](/filings/0001104659-26-032049.md) | [2.4](/filings/0001104659-26-061193.md) | [2.8](/filings/0001104659-26-094035.md) | [2.0](/filings/0001104659-25-110313.md) | [2.7 d](/filings/0001104659-26-032049.md) | [1.1](/filings/0001104659-26-061193.md) | [0.6](/filings/0001104659-26-094035.md) |
| Operating income | $m | [(0.4)](/filings/0001654954-24-014176.md) | [(6.6) d](/filings/0001654954-25-004433.md) | [(0.5)](/filings/0001654954-25-005221.md) | [0.1](/filings/0001654954-25-009449.md) | [(0.9)](/filings/0001104659-25-110313.md) | [(1.1) d](/filings/0001104659-26-032049.md) | [0.4](/filings/0001104659-26-061193.md) | [0.0](/filings/0001104659-26-094035.md) | [(4.9)](/filings/0001104659-25-110313.md) | [(3.9) d](/filings/0001104659-26-032049.md) | [(7.5)](/filings/0001104659-26-061193.md) | [(7.0)](/filings/0001104659-26-094035.md) |
| Interest expense | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Income tax | $m | [0.0](/filings/0001654954-24-014176.md) | [0.0 d](/filings/0001654954-25-004433.md) | [0.0](/filings/0001654954-25-005221.md) | [0.0](/filings/0001654954-25-009449.md) | [0.0](/filings/0001654954-24-014176.md) | [0.0 d](/filings/0001104659-26-032049.md) | [0.0](/filings/0001654954-25-005221.md) | [0.0](/filings/0001654954-25-009449.md) | [0.0](/filings/0001104659-25-110313.md) | [0.0 d](/filings/0001104659-26-032049.md) | not reported | [0.0](/filings/0001104659-26-094035.md) |
| Net income | $m | [(1.6)](/filings/0001654954-24-014176.md) | [(3.6) d](/filings/0001654954-25-004433.md) | [(0.3)](/filings/0001104659-25-110313.md) | [0.2](/filings/0001104659-25-110313.md) | [(0.7)](/filings/0001104659-25-110313.md) | [(0.9) d](/filings/0001104659-26-032049.md) | [0.5](/filings/0001104659-26-094035.md) | [0.2](/filings/0001104659-26-094035.md) | [(4.8)](/filings/0001104659-25-110313.md) | [(0.3) d](/filings/0001104659-26-032049.md) | [(11.3)](/filings/0001104659-26-094035.md) | [0.1](/filings/0001104659-26-094035.md) |
| Diluted EPS | $ per share | [107647317.00](/filings/0001654954-24-014176.md) | not reported | [0.00](/filings/0001654954-25-005221.md) | [108943126.00](/filings/0001654954-24-010214.md) | [(0.01)](/filings/0001104659-25-110313.md) | not reported | [0.00](/filings/0001654954-25-005221.md) | not reported | [(0.04)](/filings/0001104659-25-110313.md) | not reported | [(0.08)](/filings/0001104659-26-061193.md) | not reported |
| Basic EPS | $ per share | [107647317.00](/filings/0001654954-24-014176.md) | not reported | [0.00](/filings/0001654954-25-005221.md) | [108438984.00](/filings/0001654954-24-010214.md) | [(0.01)](/filings/0001104659-25-110313.md) | not reported | [0.00](/filings/0001654954-25-005221.md) | not reported | [(0.04)](/filings/0001104659-25-110313.md) | not reported | [(0.08)](/filings/0001104659-26-061193.md) | not reported |

- Revenue: us-gaap:Revenues, us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Cost of revenue: us-gaap:CostOfRevenue
- Gross profit: us-gaap:GrossProfit
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: not reported
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [12.9](/filings/0001654954-23-014107.md) | [11.9](/filings/0001654954-25-004433.md) | [11.9](/filings/0001654954-24-006358.md) | [12.4](/filings/0001654954-24-010214.md) | [13.0](/filings/0001654954-24-014176.md) | [18.2](/filings/0001104659-26-032049.md) | not reported | not reported | not reported | [30.5](/filings/0001104659-26-032049.md) | not reported | not reported |
| Current assets | $m | [16.6](/filings/0001654954-23-014107.md) | [14.1](/filings/0001654954-25-004433.md) | [14.0](/filings/0001654954-24-006358.md) | [14.6](/filings/0001654954-24-010214.md) | [15.0](/filings/0001654954-24-014176.md) | [20.7](/filings/0001104659-26-032049.md) | [24.8](/filings/0001654954-25-005221.md) | [17.7](/filings/0001654954-25-009449.md) | [31.8](/filings/0001104659-25-110313.md) | [54.7](/filings/0001104659-26-094035.md) | [48.4](/filings/0001104659-26-061193.md) | [76.6](/filings/0001104659-26-094035.md) |
| Total assets | $m | [30.9](/filings/0001654954-23-014107.md) | [28.1](/filings/0001654954-25-004433.md) | [28.0](/filings/0001654954-24-006358.md) | [28.9](/filings/0001654954-24-010214.md) | [29.8](/filings/0001654954-24-014176.md) | [34.6](/filings/0001104659-26-032049.md) | [39.5](/filings/0001654954-25-005221.md) | [47.5](/filings/0001654954-25-009449.md) | [79.9](/filings/0001104659-25-110313.md) | [154](/filings/0001104659-26-094035.md) | [148](/filings/0001104659-26-061193.md) | [191](/filings/0001104659-26-094035.md) |
| Current liabilities | $m | [1.3](/filings/0001654954-23-014107.md) | [0.9](/filings/0001654954-25-004433.md) | [0.9](/filings/0001654954-24-006358.md) | [1.3](/filings/0001654954-24-010214.md) | [2.4](/filings/0001654954-24-014176.md) | [4.0](/filings/0001104659-26-032049.md) | [4.7](/filings/0001654954-25-005221.md) | [8.0](/filings/0001654954-25-009449.md) | [6.3](/filings/0001104659-25-110313.md) | [10.2](/filings/0001104659-26-094035.md) | [13.4](/filings/0001104659-26-061193.md) | [6.6](/filings/0001104659-26-094035.md) |
| Total liabilities | $m | [1.8](/filings/0001654954-23-014107.md) | [2.6](/filings/0001654954-25-004433.md) | [2.6](/filings/0001654954-24-006358.md) | [3.2](/filings/0001654954-24-010214.md) | [4.6](/filings/0001654954-24-014176.md) | [6.0](/filings/0001104659-26-032049.md) | [6.9](/filings/0001654954-25-005221.md) | [10.0](/filings/0001654954-25-009449.md) | [8.1](/filings/0001104659-25-110313.md) | [13.0](/filings/0001104659-26-094035.md) | [16.2](/filings/0001104659-26-061193.md) | [9.6](/filings/0001104659-26-094035.md) |
| Long-term debt | $m | [0.2](/filings/0001654954-23-014107.md) | [0.0](/filings/0001654954-25-004433.md) | [0.0](/filings/0001654954-24-006358.md) | [0.3](/filings/0001654954-24-010214.md) | [0.2](/filings/0001654954-24-014176.md) | [0.2](/filings/0001104659-26-032049.md) | [0.2](/filings/0001654954-25-005221.md) | [0.1](/filings/0001654954-25-009449.md) | [0.1](/filings/0001104659-25-110313.md) | [0.1](/filings/0001104659-26-094035.md) | [0.0](/filings/0001104659-26-061193.md) | [0.2](/filings/0001104659-26-094035.md) |
| Current portion of debt | $m | [0.1](/filings/0001654954-23-014107.md) | [0.0](/filings/0001654954-25-004433.md) | [0.0](/filings/0001654954-24-006358.md) | [0.1](/filings/0001654954-24-010214.md) | [0.1](/filings/0001654954-24-014176.md) | [0.1](/filings/0001104659-26-032049.md) | [0.1](/filings/0001654954-25-005221.md) | [0.1](/filings/0001654954-25-009449.md) | [0.1](/filings/0001104659-25-110313.md) | [0.1](/filings/0001104659-26-094035.md) | [0.1](/filings/0001104659-26-061193.md) | [0.2](/filings/0001104659-26-094035.md) |
| Shareholders' equity | $m | [29.1](/filings/0001654954-24-014176.md) | [25.5](/filings/0001104659-26-032049.md) | [25.4](/filings/0001104659-25-110313.md) | [25.7](/filings/0001104659-25-110313.md) | [25.1](/filings/0001104659-25-110313.md) | [28.6](/filings/0001104659-26-094035.md) | [32.6](/filings/0001104659-26-094035.md) | [37.5](/filings/0001104659-26-094035.md) | [71.8](/filings/0001104659-25-110313.md) | [141](/filings/0001104659-26-094035.md) | [132](/filings/0001104659-26-094035.md) | [181](/filings/0001104659-26-094035.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebtNoncurrent, us-gaap:LongTermDebt
- Current portion of debt: us-gaap:LongTermDebtCurrent
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [(0.6) d](/filings/0001654954-23-014107.md) | [(0.9) d](/filings/0001654954-25-004433.md) | [0.1](/filings/0001654954-25-005221.md) | [0.6 d](/filings/0001654954-25-009449.md) | [0.4 d](/filings/0001104659-25-110313.md) | [1.2 d](/filings/0001104659-26-032049.md) | [(1.7)](/filings/0001104659-26-061193.md) | [(0.6) d](/filings/0001104659-26-094035.md) | [(3.9) d](/filings/0001104659-25-110313.md) | [(3.5) d](/filings/0001104659-26-032049.md) | [(12.1)](/filings/0001104659-26-061193.md) | [(8.7) d](/filings/0001104659-26-094035.md) |
| Capital expenditure | $m | [0.1 d](/filings/0001654954-24-014176.md) | [0.2 d](/filings/0001654954-25-004433.md) | [0.1](/filings/0001654954-25-005221.md) | [0.1 d](/filings/0001654954-25-009449.md) | [0.1 d](/filings/0001104659-25-110313.md) | [0.2 d](/filings/0001104659-26-032049.md) | [0.9](/filings/0001104659-26-061193.md) | [6.5 d](/filings/0001104659-26-094035.md) | [8.7 d](/filings/0001104659-25-110313.md) | [11.7 d](/filings/0001104659-26-032049.md) | [12.6](/filings/0001104659-26-061193.md) | [10.2 d](/filings/0001104659-26-094035.md) |
| Dividends paid | $m | [0.0 d](/filings/0001654954-24-014176.md) | [0.0 d](/filings/0001654954-25-004433.md) | [0.0](/filings/0001654954-24-006358.md) | [0.0 d](/filings/0001654954-24-010214.md) | [0.0 d](/filings/0001654954-24-014176.md) | [0.0 d](/filings/0001654954-25-004433.md) | not reported | not reported | not reported | not reported | not reported | not reported |
| Share repurchases | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | [0.0 d](/filings/0001104659-26-032049.md) | [5.0](/filings/0001104659-26-061193.md) | [2.8 d](/filings/0001104659-26-094035.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Dividends paid: us-gaap:PaymentsOfDividends
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [108](/filings/0001654954-23-014107.md) | [107](/filings/0001654954-23-012628.md) | [108](/filings/0001654954-23-013006.md) | [106](/filings/0001654954-23-014107.md) | [108](/filings/0001654954-25-005221.md) | [109](/filings/0001654954-25-009449.md) | [108](/filings/0001104659-25-110313.md) | [122](/filings/0001104659-26-061193.md) | [127](/filings/0001104659-26-094035.md) | [123](/filings/0001104659-25-110313.md) | [142](/filings/0001104659-26-061193.md) | [152](/filings/0001104659-26-094035.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 149,669,384 at 2026-08-07, from the cover of the [10-Q filed 2026-08-11](/filings/0001104659-26-094035.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:21 ET. No prices; not investment advice.